Live
- Centre okays Rs 3,689cr investment for 2 hydro electric projects in Arunachal
- IPL 2025 Auction: 13-year-old Vaibhav Suryavanshi becomes youngest player to be signed in tournament's history
- About 62 lakh foreign tourists arrived in India in 8 months this year: Govt
- IPL 2025 Auction: Gujarat bag Sherfane Rutherford for Rs 2.60 cr; Kolkata grab Manish Pandey for Rs 75 lakh
- Assam CM meets Governor, cabinet expansion on the cards
- IPL 2025 Auction: RCB buy Jacob Bethell for Rs 2.6 cr; Ellis sold to CSK for Rs 2 crore
- Commercial coal mines register highest-ever single day dispatches at 0.62 million tonnes
- More German companies adopting AI applications: statistics
- NASA Issues Warning About 170-Foot Asteroid Heading Towards Earth at 47,644 KM/H
- One killed, three injured in cargo plane crash near Vilnius airport
Centre approves nasal vaccine
Centre approves nasal vaccine
Highlights
Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform on Friday evening, official sources said.
New Delhi: Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform on Friday evening, official sources said.
The needle-free vaccine will be available at private hospitals as of now and can be administered as a precaution dose to adults who have been vaccinated with two doses of either Covishield or Covaxin. It is likely to be rolled out in the national Covid vaccination programme soon, they said. The ministry's approval for the intranasal vaccine as a booster comes amid a spurt in Covid cases in China and some other countries.
Next Story
ADVERTISEMENT
